Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Indian Journal of Hematology and Blood Transfusion
Published in: Indian Journal of Hematology and Blood Transfusion 1/2016

01-06-2016 | Correspondence

Development of Acute Promyelocytic Leukemia in a Patient With Gouty Arthritis on Long Term Colchicine

Authors: Nurhilal Buyukkurt, Asli Korur, Can Boga

Published in: Indian Journal of Hematology and Blood Transfusion | Special Issue 1/2016

Login to get access

Abstract

Colchicine is a frequently used drug in rheumatological diseases. Acute promyelocytic leukemia developed in a patient who used colchicine for gouty arthritis since 10 years is presented and the possible relation between the long term use of colchicine and hematological malignancies is discussed.
Literature
1.
Ozdogu H, Boga C, Yılmaz Z, Sahin FI, Bal N (2007) Long-term colchicine therapy in a patient with Behçet’s disease and acute promyelocytic leukemia. Rheumatol Int 27:763–765CrossRefPubMed
2.
Kuo CF, Luo SF, See LC, Chou IJ, Fang YF, Yu KH (2012) Increased risk of c ancer among gout patients; a nationwide population study. Joint Bone Spine 79(4):375–378CrossRefPubMed
3.
Ramadan SM, Fouad TM, Summa V, Hasan SKH, Lo-Coco F (2012) Acute myeloid leukemia developing in patients with autoimmune diseases. Haematologica 97:805–817CrossRefPubMedPubMedCentral
4.
Krishnan E, Chen L (2013) Trends in physician diagnosed gout and gout therapies in the US: results from the national ambulatory health care surveys 1993 to 2009. Arthritis Res Ther 15:R181CrossRefPubMedPubMedCentral
5.
Bryce SM, Avlasevich SL, Bemis JC, Phonethepswath S, Dertinger SD (2010) Miniaturized flow cytometric in vitro micronucleus assay represents an efficient tool for comprehensively characterizing genotoxicity dose-response relationships. Mutat Res 703:191–199CrossRefPubMedPubMedCentral
Metadata
Title
Development of Acute Promyelocytic Leukemia in a Patient With Gouty Arthritis on Long Term Colchicine
Authors
Nurhilal Buyukkurt
Asli Korur
Can Boga
Publication date
01-06-2016
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue Special Issue 1/2016
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-015-0523-4

Other articles of this Special Issue 1/2016

Indian Journal of Hematology and Blood Transfusion 1/2016 Go to the issue

Case Report

Resolution of Serologic Problems Due to Cold Agglutinins in Chronic Lymphocytic Leukemia

Correspondence

Prevalence and Viral Load of Human Parvovirus B19 (B19V) Among Blood Donors in South-East Brazil

Case Report

Congenital Dyserythropoietic Anemia Type 1: Report of One Patient and Analysis of Previously Reported Patients Treated with Interferon Alpha

Correspondence

APL-The Age-Old Harlequin: Do We See it All?

Case Report

The Successful Complete Remission Induction by Sorafenib Monotherapy in a FLT3-D835Y-Positive Patient with Refractory Acute Monocytic Leukemia

Correspondence

Complete Remission of Burkitt Lymphoma After Surgical Excision: A Case Report
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits